Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine versus placebo added to pregabalin for painful diabetic neuropathy
IRCT20120215009014N540Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic neuropathy comparing Pregabalin + agomelatine with Pregabalin + placebo (2 arms). Primary endpoints: Average pain score, Average sleep disorder score and 2 more. Started Feb 2025; status: completed.
02
Drugs
agomelatine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20120215009014N540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N540.